Literature DB >> 6546659

Familial erythrophagocytic reticulosis. Complete response to combination chemotherapy.

M M Delaney, E A Shafford, A Al-Attar, J Pritchard.   

Abstract

Two infants with familial erythrophagocytic reticulosis attained a durable complete remission after combination chemotherapy including intrathecal methotrexate. Though both later died, neither child had definitive evidence of tumour at necropsy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6546659      PMCID: PMC1628480          DOI: 10.1136/adc.59.2.173

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  7 in total

1.  Familial haemophagocytic reticulosis.

Authors:  J W FARQUHAR; A E CLAIREAUX
Journal:  Arch Dis Child       Date:  1952-12       Impact factor: 3.791

2.  Chemotherapy of malignant histiocytosis in adults.

Authors:  M Alexander; J R Daniels
Journal:  Cancer       Date:  1977-03       Impact factor: 6.860

Review 3.  Familial erythrophagocytic lymphohistocytosis. Report of two cases and clinicopathologic review.

Authors:  M C Perry; E G Harrison; E O Burgert; G S Gilchrist
Journal:  Cancer       Date:  1976-07       Impact factor: 6.860

4.  Hemophagocytic reticulosis. A case report with investigations of immune and white cell function.

Authors:  P Fullerton; H Ekert; C Hosking; G P Tauro
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

5.  Familial erythrophagocytic lymphohistiocytosis: treatment with vinblastine-loaded platelets.

Authors:  S Y Woo; R S Klappenbach; G M McCullars; D M Kerwin; G Rowden; L F Sinks
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

6.  Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213.

Authors:  D R Ambruso; T Hays; W J Zwartjes; D G Tubergen; B E Favara
Journal:  Cancer       Date:  1980-05-15       Impact factor: 6.860

7.  The treatment of familial erythrophagocytic lymphohistiocytosis.

Authors:  J S Lilleyman
Journal:  Cancer       Date:  1980-08-01       Impact factor: 6.860

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.